Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.

× No keyword cloud information.

18 in total

Review 1. The current role of platelet-active drugs in ischaemic heart disease.

Authors: D M Kerins; G A FitzGerald
Journal: Drugs Date: 1991-05 Impact factor: 9.546

Review 2. The potential role of thromboxane inhibitors in preventing myocardial ischaemic injury.

Authors: J L Mehta; W W Nichols
Journal: Drugs Date: 1990-11 Impact factor: 9.546

3. 5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.

Authors: F De Clerck; W Loots; Y Somers; J Beetens; L Wouters; J Wynants; P A Janssen
Journal: Br J Pharmacol Date: 1990-04 Impact factor: 8.739

Review 4. The haemostatic function of the vascular endothelial cell.

Authors: H A Bull; S J Machin
Journal: Blut Date: 1987-08

5. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.

Authors: D J Fitzgerald; J Doran; E Jackson; G A FitzGerald
Journal: J Clin Invest Date: 1986-02 Impact factor: 14.808

Review 6. Current issues in thrombosis prevention with antiplatelet drugs.

Authors: G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal: Drugs Date: 1986-06 Impact factor: 9.546

7. Stenosis and vascular damage as a cause of thrombosis in the dog femoral artery.

Authors: M Prosdocimi; A Zatta; M Finesso
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1988-10 Impact factor: 3.000

8. Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.

Authors: D J Fitzgerald; J Fragetta; G A FitzGerald
Journal: J Clin Invest Date: 1988-11 Impact factor: 14.808

9. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01).

Authors: M J Randall; R I Wilding
Journal: Br J Clin Pharmacol Date: 1983 Impact factor: 4.335

10. Effects of thromboxane synthase inhibitors on renal function.

Authors: E K Jackson; F Goto; H D Uderman; R J Workman; W A Herzer; G A FitzGerald; R A Branch
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1988-02 Impact factor: 3.000